Proliferative Glomerulonephritis With Fibrils, Monoclonal κ Light Chain, and C3 Deposits
Adam Steinberg(The Royal Melbourne Hospital), Thomas Barbour(The Royal Melbourne Hospital), Ahida Batrouney(The Royal Melbourne Hospital), Sébastien Bender(Centre National de la Recherche Scientifique), Piers Blombery(The University of Melbourne), Lucy C. Fox(Peter MacCallum Cancer Centre), Frank Bridoux(Université de Poitiers), Christophe Sirac(Centre National de la Recherche Scientifique), Surender Juneja(The Royal Melbourne Hospital), Moira Finlay(The Royal Melbourne Hospital), Guy Touchard(Centre Hospitalier Universitaire de Poitiers)
Cited by 4
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
|Nature Reviews Nephrology|2018|544
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant
|Blood|2012|543
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
|New England Journal of Medicine|2007|520